Acuren Corp. Reports Director/Officer Changes and Compensation
Ticker: TICAW · Form: 8-K · Filed: Mar 4, 2025 · CIK: 2032966
| Field | Detail |
|---|---|
| Company | Acuren Corp (TICAW) |
| Form Type | 8-K |
| Filed Date | Mar 4, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, compensation
TL;DR
Acuren Corp. filed an 8-K for director/officer changes and compensation adjustments as of Feb 28, 2025.
AI Summary
Acuren Corp. filed an 8-K on March 4, 2025, reporting events as of February 28, 2025. The filing pertains to the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements for certain officers. Specific details regarding the individuals involved, their roles, and the nature of the compensatory arrangements are not provided in this excerpt.
Why It Matters
This filing indicates potential shifts in Acuren Corp.'s leadership and executive compensation structure, which could impact the company's strategic direction and operational management.
Risk Assessment
Risk Level: medium — Changes in directors and officers, along with compensation adjustments, can signal underlying strategic shifts or governance issues that may affect the company's future performance.
Key Numbers
- 001-42524 — SEC File Number (Identifies Acuren Corp.'s filing with the SEC.)
- 20250228 — Date of Report (The earliest event date reported in the 8-K filing.)
- 20250304 — Filing Date (The date the 8-K was officially filed with the SEC.)
Key Players & Entities
- Acuren Corp. (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- Tomball, Texas (location) — Principal executive offices
FAQ
What specific changes occurred regarding directors or officers of Acuren Corp. as of February 28, 2025?
The filing indicates the departure of directors or certain officers and the election of directors and appointment of certain officers, but the specific individuals and their roles are not detailed in this excerpt.
What are the details of the compensatory arrangements for Acuren Corp.'s officers mentioned in the filing?
The filing notes that compensatory arrangements of certain officers are being reported, but the specific terms and amounts are not provided in this excerpt.
What is Acuren Corp.'s principal executive office address?
Acuren Corp.'s principal executive offices are located at 14434 Medical Complex Drive, Suite 100, Tomball, Texas 77377.
What is Acuren Corp.'s SEC file number?
Acuren Corp.'s SEC file number is 001-42524.
What is the fiscal year end for Acuren Corp.?
Acuren Corp.'s fiscal year ends on December 31.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 4, 2025 regarding ACUREN CORP (TICAW).